Vertex Pharmaceuticals stock falls after pain drug fails in Phase 2 study
Juan Miguel Mendoza, a director at Herbalife Ltd. (NYSE:HLF), recently acquired 5,000 shares of the company’s common stock, according to a filing with the Securities and Exchange Commission. The purchase, made on February 27, totaled approximately $41,250, with each share priced at $8.25. The stock, which InvestingPro analysis indicates is currently undervalued, has gained over 21% year-to-date, trading at an attractive P/E ratio of 3.3x. Following this transaction, Mendoza holds a total of 132,500 shares in the company, representing a significant position in the nutrition company, which currently has a market capitalization of $825 million. For deeper insights into insider trading patterns and comprehensive financial analysis, consider exploring the detailed Pro Research Report available on InvestingPro.
In other recent news, Herbalife Nutrition Ltd reported impressive financial results for the fourth quarter of 2024, significantly exceeding earnings expectations. The company achieved an earnings per share (EPS) of $0.36, far surpassing the anticipated $0.11, marking a 227% positive surprise. Herbalife’s revenue also exceeded forecasts, reaching $1.2 billion, which was $10 million above expectations. This strong performance was attributed to strategic product launches and expanded distribution channels. Meanwhile, High Liner Foods reported a 1.3% increase in sales volume for the fourth quarter, with adjusted EBITDA rising by 8.7% to $23.8 million. The company attributed its success to strong execution across its organization and strategic investments in promotions and innovations. High Liner Foods also participated in financing rounds for two Norwegian aquaculture companies, investing approximately $6 million in NorCOD and $10 million in Anfjord, to reinforce its position in sustainable seafood. Both companies have expressed readiness to navigate ongoing market challenges and continue exploring growth opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.